Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations.
Saved in:
| Title: | Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations. |
|---|---|
| Authors: | Liu Q; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China., Lin RR; Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310009, China. |
| Source: | Aging and disease [Aging Dis] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: JKL International Country of Publication: United States NLM ID: 101540533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-5250 (Electronic) Linking ISSN: 21525250 NLM ISO Abbreviation: Aging Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2152-5250 |
|---|---|
| DOI: | 10.14336/AD.2026.0292 |
